New $1 billion fund aims to steer antibiotic companies in tough market Antibiotics, Biotech, Business, International Federation of Pharmaceutical Manufacturers & Associations, Product Pipelines, Public Health A new $1 billion fund backed by 20 drugmakers including Merck & Co. Inc. and Pfizer Inc. is aiming to bolster struggling antibiotic companies and sustain a pipeline for new treatments. Read more July 9, 2020/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/07/New-1-billion-fund-aims-to-steer-antibiotic-companies-in-tough-market-Reuters-7-9-20.jpeg 252 370 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2020-07-09 08:53:132020-07-15 21:23:38New $1 billion fund aims to steer antibiotic companies in tough market